These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2300525)

  • 1. Improved cancer chemotherapy. Benefits of delivery by infusion.
    Lokich JJ
    Postgrad Med; 1990 Feb; 87(2):239-41, 244-6. PubMed ID: 2300525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
    Lokich JJ; Moore CL; Anderson NR
    Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies.
    Posey JA; Wang H; Hamilton J; Delgrosso A; Zhang R; Freda T; Zamboni WC
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):182-8. PubMed ID: 15838660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
    Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
    Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.
    Sørbye H; Glimelius B; Berglund A; Fokstuen T; Tveit KM; Braendengen M; Øgreid D; Dahl O
    J Clin Oncol; 2004 Jan; 22(1):31-8. PubMed ID: 14701765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.
    Maksymiuk AW; Jett JR; Earle JD; Su JQ; Diegert FA; Mailliard JA; Kardinal CG; Krook JE; Veeder MH; Wiesenfeld M
    J Clin Oncol; 1994 Jan; 12(1):70-6. PubMed ID: 8270988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy--present status and problems].
    Furue H
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):589-96. PubMed ID: 10234287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group.
    Goldberg RM; Jett JR; Therneau TM; Johnson PS; Tschetter LK; Krook JE; Veeder MH; Owen D; Etzell PS; Andres DF
    J Natl Cancer Inst; 1990 Dec; 82(24):1899-903. PubMed ID: 2174464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two schedules of application for mesna and their influence on the thiol-metabolism.
    Kempgens B; Kisro J; Gruber Y; Bahrs H; Wagner T
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):608-9. PubMed ID: 14692714
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.
    Hortobagyi GN; Frye D; Buzdar AU; Ewer MS; Fraschini G; Hug V; Ames F; Montague E; Carrasco CH; Mackay B
    Cancer; 1989 Jan; 63(1):37-45. PubMed ID: 2910423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
    Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
    Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning point for colorectal cancer clinical trials.
    Meropol NJ
    J Clin Oncol; 2006 Jul; 24(21):3322-4. PubMed ID: 16849744
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
    Zalupski M; Metch B; Balcerzak S; Fletcher WS; Chapman R; Bonnet JD; Weiss GR; Ryan J; Benjamin RS; Baker LH
    J Natl Cancer Inst; 1991 Jul; 83(13):926-32. PubMed ID: 2067035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies.
    Miglietta L; Marenghi C; Nizzo R; Foglia G; Ragni N; Boccardo F
    Oncology; 2001; 60(2):116-22. PubMed ID: 11244325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy in metastatic colorectal cancer.
    Hansen RM
    Arch Intern Med; 1990 Nov; 150(11):2265-9. PubMed ID: 2241436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion.
    Lokich J; Bern M; Anderson N; Wallach S; Moore C; Beauchamp K; Williams D
    Cancer; 1989 Mar; 63(5):822-4. PubMed ID: 2914289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
    de Gramont A; Bosset JF; Milan C; Rougier P; Bouché O; Etienne PL; Morvan F; Louvet C; Guillot T; François E; Bedenne L
    J Clin Oncol; 1997 Feb; 15(2):808-15. PubMed ID: 9053508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer chemotherapy and infusional scheduling.
    Anderson N; Lokich JJ
    Oncology (Williston Park); 1994 May; 8(5):99-111; discussion 111, 115-6. PubMed ID: 8025010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.